DT-061

DT-061 is an orally bioavailable activator of protein phosphatase 2A (PP2A) and could be applied in the therapy of KRAS-mutant and MYC-driven tumorigenesis.


Cat. No.: EX-A5068	Purity: >98%

	Chemical structure of DT-061

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
25mg	496	In-stock
50mg	775	In-stock
100mg	1250	In-stock
250mg	get quote	In-stock
500mg	get quote	In-stock
1g	get quote	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


CAS No.	1809427-19-7
Purity	>98%
Formula	C25H23F3N2O5S
Mol Weight	520.521
Color	Off-white to light yellow
State	solid powder
Solubility	Soluble in DMSO 125 mg/mL
Shelf Life	>2 years if stored properly
Storage	Powder -20℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Kauko O, et al. PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells. Sci Transl Med. 2018 Jul 18;10(450). pii: eaaq1093.
CoA	CoA of DT-061

Smiles:	O=S(C1=CC=C(OC(F)(F)F)C=C1)(N[C@H]2[C@H](O)[C@@H](N3C4=C(C=CC=C4)OC5=CC=CC=C35)CCC2)=O


		Search